-
Divi’s Laboratories Share Price Hits a Record High, Up 84% This Year: Buy, Sell or Hold After the Q2 FY27 Profit Jump?
- November 9, 2026
- Posted by: Ankit Jaiswal
- Category: News
No Comments
Divi’s Laboratories share price hit a record high after Q2 FY27 profit rose 64% to Rs 1,127 crore. Results, valuation and analyst views, without a buy call.
-
Gland Pharma Share Price Jumps to a 52-Week High Despite the Market Sell-Off: Q2 FY27 Profit, CDMO Growth and What to Check
- November 9, 2026
- Posted by: Chaitanya Auti
- Category: News
Gland Pharma share price jumped 7% to a 52-week high after Q2 FY27 profit rose 58% to Rs 290.8 crore. Results, CEO change, valuation and checks.
-
Pharma and Healthcare Stocks: A Defensive Theme for Samvat 2083 After Nifty Pharma’s 21% Gain in Samvat 2082?
- November 5, 2026
- Posted by: Chaitanya Auti
- Category: Market
Nifty Pharma rose 21.4% in Samvat 2082. Are pharma and healthcare stocks still a defensive theme for Samvat 2083? Growth drivers, US tariffs and risks.
-
Nifty Pharma Stocks to Buy in November 2026: 5 Names on the Watchlist
- November 5, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Five Nifty Pharma stocks on the November 2026 watchlist with FY26 growth, valuation, ROE, shareholding and risks for Sun Pharma, Lupin, Divi’s Labs, Ipca Labs and Ajanta Pharma.
-
Sanofi India Dividend of Rs 75 Per Share: Record Date, Yield, Past Payouts and What Investors Should Know
- November 4, 2026
- Posted by: Chaitanya Auti
- Category: News
Sanofi India dividend of Rs 75 per share: record date, yield at the current price, past payouts and what the ex-dividend date means for investors.
-
Emcure Pharma Share Price Hits Record High After Q2 FY27 Results: Profit, Margins and What Drove the Rally
- November 4, 2026
- Posted by: Kunal Singla
- Category: Results
Emcure Pharma share price hit a record high after Q2 FY27 results. See revenue, profit, margins, overseas growth, valuation and key risks.
-
Sun Pharma Q2 FY27 Results: Net Profit Falls 36% to Rs 1,989 Crore on Rs 1,269 Crore One-Time Charges, While Adjusted Profit Rises 1.4% and Revenue Climbs 12%
- November 2, 2026
- Posted by: Kunal Singla
- Category: Results
Sun Pharma Q2 results: profit fell 36% to Rs 1,989 crore on one-time charges, but adjusted profit rose 1.4% and revenue 12%. India strong, US weak. Share price and what to watch.
-
Sudarshan Pharma Share Price Reverses From Rs 39 to Rs 36.42 on 30 October 2026 as Profit Booking Follows 86% Profit Jump in Sudarshan Pharma Q2 Results: Will the Small-Cap Pharma Stock Rebound?
- October 30, 2026
- Posted by: Chaitanya Auti
- Category: Results
Sudarshan Pharma share price fell to Rs 36.42 after opening 5.5% higher on Q2 results with profit up 86%. Up 30% plus this year, will the small-cap pharma stock rebound after profit booking?
-
Laurus Labs Share Price Jumps 5.35% to Record High of Rs 2,381.90 on 30 October 2026 as Laurus Labs Q2 Results Show Profit Up 126% and Rs 1 Laurus Labs Dividend Declared: Should You Buy?
- October 30, 2026
- Posted by: Kunal Singla
- Category: Results
Laurus Labs share price hit a record Rs 2,381.90 on 30 October 2026 after Q2 FY27 profit rose 126% to Rs 441 crore and a Rs 1 interim dividend was declared. Targets and should you buy.
-
F&O Stocks to Buy: CDSL, Zydus Lifesciences and Sun Pharma on Jay Thakkar’s Near-Term List, With Price Levels, Technicals and Risks
- October 28, 2026
- Posted by: Harsh Piplani
- Category: News
F&O stocks to buy named by Jay Thakkar: CDSL, Zydus Lifesciences and Sun Pharma. See price levels, technicals, fundamentals and risks, and why range-bound markets matter.